A Gd-doped Mg-Al-LDH/Au nanocomposite for CT/MR bimodal imagings and simultaneous drug delivery

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3390-3401

  Wang, Lijun ^a   Xing, Huaiyong ^a   Zhang, Shengjian ^b   Ren, Qingguo ^c   Pan, Limin ^a   Zhang, Kun ^a   Bu, Wenbo ^a   Zheng, Xiangpeng ^c   Zhou, Liangping ^b   Peng, Weijun ^b   Hua, Yanqing ^c   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

CT imaging; Dual modality imaging; Intracellular anti cancer drug delivery; Layered double hydroxides (LDHs); MR imaging

Indexed keywords

ANTI-CANCER DRUG DELIVERY; CT IMAGING; DUAL-MODALITY IMAGING; LAYERED DOUBLE HYDROXIDES; MR IMAGING;

CELLS; CYTOLOGY; DIAGNOSIS; DISEASES; DRUG DELIVERY; GADOLINIUM; GOLD; LOADING; MAGNETIC RESONANCE IMAGING; MAMMALS; POSITRON EMISSION TOMOGRAPHY; TUMORS;

NANOCOMPOSITES;

ALUMINUM; DIAGNOSTIC AGENT; DOXORUBICIN; GADOLINIUM; GADOLINIUM PENTETATE MEGLUMINE; GOLD; HEPARIN; HYDROXIDE; IOBITRIDOL; LAYERED DOUBLE HYDROXIDE; MAGNESIUM; MOLECULAR LAYER; NANOCARRIER; NANOCOMPOSITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BREAST TUMOR; CANCER CELL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY DEVICE; DRUG MECHANISM; DRUG RELEASE; DRUG TRANSPORT; HUMAN; HUMAN CELL; MOUSE; NANOPHARMACEUTICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RADIODIAGNOSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; GADOLINIUM; GOLD; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROXIDES; INTRACELLULAR SPACE; MAGNETIC RESONANCE IMAGING; MICE; NANOCOMPOSITES; NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; X-RAY DIFFRACTION;

MUS;

EID: 84874239431     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.070     Document Type: Article

References (62)

1. Lee N., Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 2012, 41:2575-2589.
2. Sun I.C., Eun D.K., Koo H., Ko C.Y., Kim H.S., Yi D.K., et al. Tumor-targeting gold particles for dual computed tomography/optical cancer imaging. Angew Chem Int Edit 2011, 50:9348-9351.
3. Kievit F.M., Zhang M.Q. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Acc Chem Res 2011, 44:853-862.
4. Peer D., Karp J.M., Hong S., FaroKHzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
5. Xia Y.N., Li W.Y., Cobley C.M., Chen J.Y., Xia X.H., Zhang Q., et al. Gold nanocages: from synthesis to theranostic applications. Acc Chem Res 2011, 44:914-924.
6. Ambrogio M.W., Thomas C.R., Zhao Y.L., Zink J.I., Stoddartt J.F. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc Chem Res 2011, 44:903-913.
7. Ke H.T., Wang J.R., Dai Z.F., Jin Y.S., Qu E.Z., Xing Z.W., et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Edit 2011, 50:3017-3021.
8. Xie J., Lee S., Chen X.Y. Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 2010, 62:1064-1079.
9. Chou S.W., Shau Y.H., Wu P.C., Yang Y.S., Shieh D.B., Chen C.C. In vitro and in vivo studies of FePt nanoparticles for dual modal CT/MRI molecular imaging. J Am Chem Soc 2010, 132:13270-13278.
10. 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance. Biomaterials 2012, 33:5394-5405.
11. Devaraj N.K., Keliher E.J., Thurber G.M., Nahrendorf M., Weissleder R. F-18 labeled nanoparticles for in vivo PET-CT imaging. Bioconjug Chem 2009, 20:397-401.
12. de Rosales R.T.M., Tavare R., Paul R.L., Jauregui-Osoro M., Protti A., Glaria A., et al. Synthesis of Cu-64(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent. Angew Chem Int Edit 2011, 50:5509-5513.
13. Caldorera-Moore M.E., Liechty W.B., Peppas N.A. Responsive theranostic systems: Integration of diagnostic imaging agents and responsive controlled release drug delivery carriers. Acc Chem Res 2011, 44:1061-1070.
14. Lee J.E., Lee N., Kim T., Kim J., Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res 2011, 44:893-902.
15. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
16. Li S.H., Goins B., Zhang L.J., Bao A.D. Novel multifunctional theranostic liposome drug delivery system: Construction, characterization, and multimodality MR, near-Infrared fluorescent, and nuclear imaging. Bioconjug Chem 2012, 23:1322-1332.
17. Savic R., Luo L.B., Eisenberg A., Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003, 300:615-618.
18. Wijagkanalan W., Kawakami S., Hashida M. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations. Pharm Res 2011, 28:1500-1519.
19. Tassa C., Shaw S.Y., Weissleder R. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy. Acc Chem Res 2011, 44:842-852.
20. Llevot A., Astruc D. Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer. Chem Soc Rev 2012, 41:242-257.
21. Pan L.M., He Q.J., Liu J.N., Chen Y., Ma M., Zhang L.L., et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles. J Am Chem Soc 2012, 134:5722-5725.
22. He Q.J., Ma M., Wei C.Y., Shi J.L. Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging. Biomaterials 2012, 33:4392-4402.
23. Lou X.H., Wang C.Y., He L. Core-shell Au nanoparticle formation with DNA-polymer hybrid coatings using aqueous ATRP. Biomacromolecules 2007, 8:1385-1390.
24. He Q.J., Shi J.L. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem 2011, 21:5845-5855.
25. Lee D.E., Koo H., Sun I.C., Ryu J.H., Kim K., Kwon I.C. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev 2012, 41:2656-2672.
26. Zhao Y., Li F., Zhang R., Evans D.G., Duan X. Preparation of layered double-hydroxide nanomaterials with a uniform crystallite size using a new method involving separate nucleation and aging steps. Chem Mater 2002, 14:4286-4291.
27. 3: LDH formation mechanism. Chem Mater 2005, 17:1055-1062.
28. Choy J.H., Oh J.M., Park M., Sohn K.M., Kim J.W. Inorganic-biomolecular hybrid nanomaterials as a genetic molecular code system. Adv Mater 2004, 16:1181-1184.
29. 4@DFUR-LDH submicro particles for magnetically controlled drug delivery and release. Chem Commun 2011, 47:908-910.
30. Gu Z., Thomas A.C., Xu Z.P., Campbell J.H., Lu G.Q. In vitro sustained release of LMWH from MgAl-layered double hydroxide nanohybrids. Chem Mater 2008, 20:3715-3722.
31. 2@layered double hydroxide core-shell microspheres for magnetic separation of proteins. J Am Chem Soc 2012, 134:1071-1077.
32. Liu J., Harrison R., Zhou J.Z., Liu T.T., Yu C.Z., Lu G.Q., et al. Synthesis of nanorattles with layered double hydroxide core and mesoporous silica shell as delivery vehicles. J Mater Chem 2011, 21:10641-10644.
33. Bao H.F., Yang J.P., Huang Y., Xu Z.P., Hao N., Wu Z.X., et al. Synthesis of well-dispersed layered double hydroxide core@ordered mesoporous silica shell nanostructure (LDH@mSiO(2)) and its application in drug delivery. Nanoscale 2011, 3:4069-4073.
34. Xu Z.P., Stevenson G.S., Lu C.Q., Lu G.Q.M., Bartlett P.F., Gray P.P. Stable suspension of layered double hydroxide nanoparticles in aqueous solution. J Am Chem Soc 2006, 128:36-37.
35. Oh J.M., Choi S.J., Lee G.E., Han S.H., Choy J.H. Inorganic drug-delivery nanovehicle conjugated with cancer-cell-specific ligand. Adv Funct Mater 2009, 19:1617-1624.
36. Wang J., Zhou J.D., Li Z.S., Song Y.C., Liu Q., Jiang Z.H., et al. Magnetic, luminescent Eu-doped Mg-Al layered double hydroxide and its intercalation for ibuprofen. Chem-Eur J 2010, 16:14404-14411.
37. Liu C.X., Hou W.G., Li L.F., Li Y., Liu S.J. Synthesis and characterization of 5-fluorocytosine intercalated Zn-Al layered double hydroxide. J Solid State Chem 2008, 181:1792-1797.
38. Yan D.P., Lu J., Wei M., Evans D.G., Duan X. Sulforhodamine B intercalated layered double hydroxide thin film with polarized photoluminescence. J Phys Chem B 2009, 113:1381-1388.
39. 4@MgAl-LDH@Au as magnetically recyclable catalysts for catalytic oxidation of alcohols. Chem Commun 2011, 47:12804-12806.
40. 4-layered double hydroxide colloidal nanohybrids with excellent performance for treatment of organic dyes in water. J Mater Chem 2011, 21:1218-1225.
41. Chen C.P., Gunawan P., Lou X.W., Xu R. Silver nanoparticles deposited layered double hydroxide nanoporous coatings with excellent antimicrobial activities. Adv Funct Mater 2012, 22:780-787.
42. Ladewig K., Xu Z.P., Lu G.Q. Layered double hydroxide nanoparticles in gene and drug delivery. Expert Opin Drug Del 2009, 6:907-922.
43. Tyner K.M., Schiffman S.R., Giannelis E.P. Nanobiohybrids as delivery vehicles for camptothecin. J Control Release 2004, 95:501-514.
44. Xu Z.P., Lu G.Q. Layered double hydroxide nanomaterials as potential cellular drug delivery agents. Pure Appl Chem 2006, 78:1771-1779.
45. Choi S.J., Choi G.E., Oh J.M., Oh Y.J., Park M.C., Choy J.H. Anticancer drug encapsulated in inorganic lattice can overcome drug resistance. J Mater Chem 2010, 20:9463-9469.
46. Oh J.M., Choi S.J., Kim S.T., Choy J.H. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrin-mediated endocytosis. Bioconjug Chem 2006, 17:1411-1417.
47. Choy J.H., Kwak S.Y., Jeong Y.J., Park J.S. Inorganic layered double hydroxides as nonviral vectors. Angew Chem Int Edit 2000, 39:4042-4045.
48. Choy J.H., Kwak S.Y., Park J.S., Jeong Y.J. Cellular uptake behavior of [gamma-P-32] labeled ATP-LDH nanohybrids. J Mater Chem 2001, 11:1671-1674.
49. Sutton D., Wang S.H., Nasongkla N., Gao J.M., Dormidontova E.E. Doxorubicin and β-lapachone release and interaction with micellar core materials: experiment and modeling. Exp Biol Med 2007, 232:1090-1099.
50. Xu C.J., Tung G.A., Sun S.H. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 2008, 20:4167-4169.
51. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
52. Chen Y., Chen H.R., Zhang S.J., Chen F., Zhang L.X., Zhang J.M., et al. Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs. Adv Funct Mater 2011, 21:270-278.
53. Moreau F., Bond G.C., Taylor A.O. Gold on titania catalysts for the oxidation of carbon monoxide: control of pH during preparation with various gold contents. J Catal 2005, 231:105-114.
54. Liu Z.P., Ma R.Z., Osada M., Iyi N., Ebina Y., Takada K., et al. Synthesis, anion exchange, and delamination of Co-Al layered double hydroxide: assembly of the exfoliated nanosheet/polyanion composite films and magneto-optical studies. J Am Chem Soc 2006, 128:4872-4880.
55. Delgado R.R., Vidaurre M.A., De Pauli C.P., Ulibarri M.A., Avena M.J. Surface-charging behavior of Zn-Cr layered double hydroxide. J Colloid Interf Sci 2004, 280:431-441.
56. Tannock I.F., Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989, 49:4373-4384.
57. Booth C.L., Brouwer K.R., Brouwer K.L.R. Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver. Cancer Res 1998, 58:3641-3648.
58. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
59. Huang X.L., Li L.L., Liu T.L., Hao N.J., Liu H.Y., Chen D., et al. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. Acs Nano 2011, 5:5390-5399.
60. 2 dual-Modal contrast agent. Adv Mater 2012, 24:6223-6228.
61. Kim D., Park S., Lee J.H., Jeong Y.Y., Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007, 129:7661-7665.
62. Passirani C., Barratt G., Devissaguet J.P., labarre D. Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). Pharm Res 1998, 15:1046-1050.